Masterclass in Clinical Oncology - Autumn edition

HYBRID EVENT

Masterclass in Clinical Oncology - Autumn edition

HYBRID EVENT

Course leadership
Chairs: J. But Hadžic, SI - T. Cufer, SI

Host Chair: V. Guarneri, IT

Scientific Supervisor: R. Audisio, SE/IT

Course Overview
The Masterclass in Clinical Oncology is an intensive, practice-oriented course for medical and clinical oncologists with 3–4 years of experience in the field. It is designed to strengthen their skills in the multidisciplinary management of cancer, while promoting international collaboration and knowledge exchange.

Course Format

The Masterclass is divided into two complementary parts:

• Part 1 – Online Lectures

Available from 19 September 2025

Participants will access pre-recorded lectures. This allows flexible, self-paced preparation ahead of the in-person sessions.

• Part 2 – In-Person Event

24-28 October 2025

A 3.5-day residential-style course that fosters active discussion and network-building, offering direct access to experienced faculty in a collaborative and informal environment.

The Masterclass features:

o Plenary lectures: State-of-the-art treatments presented by renowned international faculty, with reference to the latest clinical guidelines

o Interactive workshops: Focused on real-world practice and decision-making

o Tumour board simulation: Each participant presents and discusses a clinical case with a panel of top experts

Language

The course will be conducted entirely in English.

Fluency in English is a requirement for admission. Translation is not provided.

Registration Fee

The course will take place at San Servolo, Venice, Italy.

If selected, a registration fee of 250 EUR will be requested.

The fee covers:

• Access to all educational sessions and course materials

• 4 nights’ accommodation

• Meals as outlined in the official programme

Travel costs are not covered and must be arranged independently.

ESO College members receive a 50% discount on the registration fee.

The fee is a non-refundable contribution towards organisational costs and will not be reimbursed in the case of withdrawal or non-attendance, regardless of the reason.

Accreditation

A certificate of attendance will be issued upon completion of:

• 75% of the online programme

• 100% attendance at the in-person Masterclass

• Completion of the evaluation questionnaire and learning assessment test for both parts

Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE).

ESO College Credits

Participation in this course grants eligibility to join the ESO College and allows existing members to earn 30 ESO College credits toward their progression.

Visit ESO College dedicated section for more information on membership and benefits.

Contacts – Organising Secretariat

Elena Fiore - efiore@eso.net

Dolores Knupfer - dknupfer@eso.net

Sonia Bugarelli - sbulgarelli@eso.net

19 Sep 2025

Masterclass in Clinical Oncology - Block 1 (PRE-RECORDED LECTURES)

24 Oct 2025 - 28 Oct 2025

Masterclass in Clinical Oncology - Autumn edition

Ainhoa Madariaga

Hospital Universitario 12 de Octubre, Medical Oncology Dpt., Madrid, ES

Alessandra Curioni-Fontecedro

Freiburger Spital, HFR Kantonsspital Freiburg, Department of Oncology, Freiburg, CH

Alessandro Gronchi

National Cancer Institute - IRCCS Foundation, Sarcomas Surgery Unit, Milano, IT

Alexander Siebenhüner

Kantonsspital Schaffhausen, Oncology Dpt., Schaffhausen, CH

Alexandru Eniu

Riviera-Chablais Hospital, Medical Oncology Dpt., Rennaz, CH

Alina Sturdza

Comprehensive Cancer Center, Medical University of Vienna, Dept. of Radiation Oncology, Wien, AT

Amanda Psyrri

Attikon University Hospital, Medical Oncology Dept., Chaidari, GR

Ambrogio Fassina

University of Padova, Pathology Anatomy Dpt., Padova, IT

An Lievrouw

Ghent University Hospital, Cancer Center Dpt., Ghent, BE

Andre D'Hoore

UZ Gasthuisberg, Dept. of Surgery, Leuven, BE

Andrea Ferrari

Fondazione IRCCS Istituto Nazionale dei Tumori, Div. di Oncologia Pediatrica, Milano, IT

Andrea Gallina

EOC - Ente Ospedaliero Cantonale, Urology Dpt., Bellinzona, CH

Andrea Gallina

EOC - Ente Ospedaliero Cantonale, Urology Dpt., Bellinzona, CH

Andrea Sartore-bianchi

Niguarda Hospital, Division of Clinical Research and Innovation, Milano, IT

Andreas Dietz

University Hospital Leipzig, ENT Dpt., Leipzig, DE

Angela Lamarca

Fundación Jiménez Díaz University Hospital, Department of Oncology – OncoHealth Institute, Madrid, ES

Annalisa Trama

National Cancer Institute - IRCCS Foundation, ., Milano, IT

Antonio Calles

University General Hospital Gregorio Maranon, Dept. of Thoracic Oncology, Madrid, ES

Antonio Di Meglio

Gustave Roussy Institute, Medical Oncology Dpt., Villejuif, FR

Barbara Alicja Jereczek-fossa

European Institute of Oncology, Dept. of Radiotherapy, Milano, IT

Beata Laki

Medical School, University of Pécs, Dept. of Behavioural Sciences, Pécs, HU

Bruno Vincenzi

University Campus Bio-Medico, Medical Oncology Dpt., Rome, IT

Carmen Criscitiello

European Institute of Oncology, New Drugs and Early Drug Development for Innovative Therapies Dpt., Milan, IT

Christian Rolfo

The Arthur G. James Comprehensive Cancer Center, Division of Medical Oncology, Columbus, OH, US

Cristiana Sessa

Istituto Oncologico della Svizzera Italiana, Gynaecology Dpt., Bellinzona, CH

Demetris Papamichael

Bank of Cyprus Oncology Centre, Medical Oncology Dpt., Nicosia, CY

Demetris Papamichael

Bank of Cyprus Oncology Centre, Medical Oncology Dpt., Nicosia, CY

Eduard Alexandru Bonci

Champalimaud Research and Clinical Centre, Breast Unit, Lisbon, PT

Elena Guerini Rocco

European Institute of Oncology IRCCS, Division of Pathology, Milan, IT

Eleonora Petra Preti

IEO - European Institute of Oncology, Gynaecological Cancer Dpt., Milan, IT

Eric Van Cutsem

University Hospital Leuven, Digestive Oncology Dept., Leuven, BE

Ernest Nadal

Institut Català d'Oncologia, Medical Oncology Department, L'Hospitalet (Barcelona), ES

Fady B. Geara

Cleveland Clinic Abu Dhabi, Dept. of Radiation Oncology, Abu Dhabi, AE

Fatima Cardoso

Champalimaud Clinical Center, Breast Unit, Lisbon, PT

Fatjona Kraja

Mother Teresa University Hospital, Oncology Dept., Tirana, AL

Fatjona Kraja

Mother Teresa University Hospital, Oncology Dept., Tirana, AL

Felipe A. Calvo Manuel

Clinica Universidad de Navarra, Dept. of Radiation Oncology, Madrid, ES

Fiorella Calabrese

University of Padova, Anatomo Pathology Dpt., Padova, IT

Fleur Helewaut

University Ghent, Faculty of Medicine and Health Sciences for the Clinical Skills Training Centre, Ghent, BE

Francesca Del Bufalo

IRCCS Peadiatric Hospital Bambino Gesù, Cellular and Genic Therapy Dpt., Roma, IT

Franco Cavalli

Foundation for the Institute of Oncology Research (IOR), Presidenza, Bellinzona, CH

Gaya Spolverato

Azienda Ospedale Università di Padova, Surgery - Gastrointestinal Cancers Dpt., Padova, IT

Giancarlo Pruneri

National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT

Giovanni Boniolo

University of Ferrara, Dept. of Neuroscience and Rehabilitation, Ferrara, IT

Giulia Baciarello

San Camillo-Forlanini Hospitals, Medical Oncology Dpt., Rome, IT

Giuseppe Curigliano

European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT

Ian Chau

Royal Marsden Hospital, Department of Medicine, Sutton, Surrey, UK

Ian Tannock

Toronto, CA

Isabelle Ray-Coquard

Léon Bérard Center, Dept. of Medical Oncology, Lyon, FR

Jarushka Naidoo

Waterford Regional Hospital, Medical Oncology Dpt., Waterford, IE

Jasna But Hadžic

Faculty of Medicine - University of Ljubljana, Dept. of Oncology, Ljubljana, SI

Joachim Schuz

AIRC - International Agency for Research on Cancer, Environment and Lifestyle Epidemiology Branch, Lyon, FR

Joerg Beyer

University Hospital of Bern, Oncology and Medicine Dept., Bern, CH

Johan De Munter

University Hospital Ghent, Oncology Dpt., Ghent, BE

Juan Francisco Grau Bejar

Vall d´Hebron University Hospital, Gynaecological Cancer Dpt., Barcelona, ES

Karim Fizazi

Gustave Roussy Institute, Cancer Medicine Dept., Villejuif, FR

Kristel Mulders

Jessa Hospital, Onco-sexology and Cancer Plan Dpt., Hasselt, BE

Loredana Mrak

University Clinic Golnik, Medical Oncology Dept., Golnik, SI

Luca Bertolaccini

IEO, Istituto Europeo di Oncologia IRCCS, Thoracic Surgery Dpt., Milano, IT

Luca Bertolaccini

IEO, Istituto Europeo di Oncologia IRCCS, Thoracic Surgery Dpt., Milano, IT

Manuela Schmidinger

Medical University of Vienna, Department of Urology and Comprehensive Cancer Center, Vienna, AT

Marco Vitellaro

Fondazione IRCCS Istituto Nazionale dei Tumori, Surgical Oncology Dpt., Milano, IT

Maria Vittoria Dieci

Istituto Oncologico Veneto, Dept. of Oncology 2, Padova, IT

Marzia Salgarello

Policlinico Gemelli, Recostructive Surgery Dpt., Rome, IT

Michel Ducreux

Institute Gustave Roussy, Oncology, Villejuif, FR

Miroslawa Puskulluoglu

Maria Sklodowska-Curie National Research Institute of Oncology, Kraków Branch, Dept. of Clinical Oncology, Krakow, PL

Nicoletta Colombo

Istituto Europeo di Oncologia, Programma Ginecologia Oncologica, Milano, IT

Olivier Michielin

Geneve University Hospital, Medical Oncology Dpt., Geneve, CH

Paolo Giovanni Casali

National Cancer Institute - IRCCS Foundation, Medical Oncology Unit 2, Milan, IT

Patrizia Giannatempo

Fondazione IRCCS Istituto Tumori, Medical Oncology Dpt., Milano, IT

Philip Poortmans

Iridium Netwerk & University of Antwerp, Dept. of Radiation Oncology, Wilrijk, BE

Riccardo A. Audisio

Institute of Clinical Sciences - Sahlgrenska University Hospital, Dept. of Surgery, Göteborg, SE

Roberto Tozzi

University of Padova, Woman and Child's Health Dept., Padova, IT

Rodrigo Dienstmann

Vall d’Hebron Institute of Oncology, Molecular Therapeutic Research Unit, Barcelona, ES

Ronan Flippot

Gustave Roussy Institute of Oncology, Urology Dpt., Villejuif, FR

Sara De Dosso

Oncology Institute of Southern Switzerland (IOSI), Medical Oncology Dpt., Bellinzona, CH

Sara Ramella

University Campus Bio-Medico, Radiotherapy Dpt., Roma, IT

Tania Fleitas Kanonnikoff

Hospital Clinico Universitario de Valencia, Clinical Oncology Dpt., Valencia, ES

Tanja Cufer

University of Ljubljana, Medical Faculty, Ljubljana, SI

Thomas Seufferlein

Ulm University Hospital, Dept. of Internal Medicine I, Ulm, DE

Umberto Malapelle

University of Naples Federico II, Dpt. of Public Health, Naples, IT

Ursula Vogl

Cantonal Hospital of Southern Switzerland (EOC), IOSI - Oncology Institute of Southern Switzerland, Bellinzona, CH

Uta Schmidt-strassburger

Ulm University, Learning and Teaching, Medical Faculty, Ulm, DE

Valentina Guarneri

University of Padova, DiSCOG, Padova, IT

Applications are now closed

Participation in the Masterclass is by competitive application only.

A maximum of 60 participants will be selected.

Who Should Apply

Applicants should meet the following criteria:

• Aged up to 40 years

• 2–3 years’ experience in clinical oncology, working with cancer patients

• Active involvement in clinical trials or scientific research

• Fluent in English

• Reside within ESO’s geographical reach: Europe, Mediterranean countries, or Latin America

Priority will also be given to candidates who:

• Have previously attended ESO’s Basic Principles of Oncology course

• Are members of ESO’s College

How to Apply

Applications must be submitted online.

You will be asked to complete a questionnaire with details about your:

Work experience and clinical training
Research activities and publications
Motivation and commitment to participate

You will also need to upload the following documents in PDF format:

Recommendation letter from your head of department or mentor (on official letterhead, signed)
Curriculum Vitae (CV)
Clinical case presentation using the official template

Download your Clinical case template HERE

Applications without the required documents will not be considered. Please ensure all files are ready before starting the application form.

You will be asked to accept ESO’s Data Protection Statement during the application process.

Selection Process

ESO uses a two-step evaluation process to ensure fairness and transparency:

Automated Scoring
Some sections are scored automatically using a predefined system.
Committee Evaluation
Your qualitative responses are reviewed by the selection committee.

Clinical Case Presentation

All participants will be invited to present a clinical case during the in-person Masterclass, as part of a grand round discussion with faculty and peers.

Your submitted case should be based on real clinical practice (not rare or unusual cases) and must include:

Diagnostic considerations
Treatment and follow-up
At least three discussion questions for the faculty

If selected, you will prepare a PowerPoint presentation (max 10 slides). In case of topic overlap within a tumour group, you may be asked to switch to your second choice, which you are encouraged to indicate during application.

ESO COLLEGE
CREDITS

HYBRID

San Servolo (Venice), Italy

ONSITE:

Oct
2025

ONLINE:

Sep
2025